Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma
Authors:
- Anna T BriniABAnna T Brini
- Seley GharaneiSeley Gharanei
- Elena ArrigoniEAElena Arrigoni
- Ashraf DallolADAshraf Dallol
- Takeshi KishidaTKTakeshi Kishida
Open Access
- 5 November 2013
- journal article
- Published by Taylor & Francis in Epigenetics
- Vol. 8 (11) , 1198-1204
Abstract
Using a candidate gene approach we recently identified frequent methylation of the RASSF2 gene associated with poor overall survival in Ewing sarcoma (ES). To identify effective biomarkers in ES on a genome-wide scale, we used a functionally proven epigenetic approach, in which gene expression was induced in ES cell lines by treatment with a demethylating agent followed by hybridization onto high density gene expression microarrays. After following a strict selection criterion, 34 genes were selected for expression and methylation analysis in ES cell lines and primary ES. Eight genes (CTHRC1, DNAJA4, ECHDC2, NEFH, NPTX2, PHF11, RARRES2, TSGA14) showed methylation frequencies of > 20% in ES tumors (range 24–71%), these genes were expressed in human bone marrow derived mesenchymal stem cells (hBMSC) and hypermethylation was associated with transcriptional silencing. Methylation of NPTX2 or PHF11 was associated with poorer prognosis in ES. In addition, six of the above genes also showed methylation frequency...Keywords
This publication has 23 references indexed in Scilit:
- RASSF2methylation is a strong prognostic marker in younger age patients with Ewing sarcomaEpigenetics, 2013
- Biomarkers in Ewing sarcoma: the promise and challenge of personalized medicine. A report from the Children’s Oncology GroupFrontiers in Oncology, 2013
- DNA methylation profiling in the clinic: applications and challengesNature Reviews Genetics, 2012
- Recent advances in the molecular pathogenesis of Ewing's sarcomaOncogene, 2010
- Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinomaOncogene, 2010
- A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer DetectionAmerican Journal of Gastroenterology, 2008
- DNA Methylation Markers and Early Recurrence in Stage I Lung CancerNew England Journal of Medicine, 2008
- Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin GeneJNCI: Journal of the National Cancer Institute, 2005
- Tumor Suppressor Activity and Epigenetic Inactivation of Hepatocyte Growth Factor Activator Inhibitor Type 2/SPINT2 in Papillary and Clear Cell Renal Cell CarcinomaCancer Research, 2005
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000